DHGWA
PRPH

Dixon Hughes Goodman Wealth Advisors’s ProPhase Labs PRPH Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1K Hold
18
– – ﹤0.01% 818
2021
Q4 		$1K Buy
+18
New +$1.12K ﹤0.01% 770

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's PRPH Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors held its ProPhase Labs (PRPH) position steady in Q1 2022 at 18 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #818.

Dixon Hughes Goodman Wealth Advisors first reported a position in PRPH in Q4 2021 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold PRPH as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 18 shares of ProPhase Labs worth $1K as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors left its ProPhase Labs share count unchanged in Q1 2022.
  • ProPhase Labs made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #818 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in ProPhase Labs in Q4 2021 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.